Company profile

Innovative Pioneering Work

Vita 34 AG in Leipzig, Germany, is a pioneer amongst the private umbilical cord blood banks in Europe and it is the largest stem cell bank in the German-speaking countries. The long-term storage of stem cells from umbilical cord blood and tissue, as well as the production of stem cell transplants with the highest level of quality and safety form the core business of Vita 34. Expecting parents can select between the autologous storage of umbilical cord blood and tissue as a private provision or a combination of personal provision and an allogeneic donation, the VitaMine&Yours product.

Since the founding of the company in 1997, Vita 34 has not only stored stem cell units, but it has also set innovative standards via in-depth research work. Vita 34 is involved in applied research in cooperation with renowned universities and research institutes and, thus, is actively shaping the development of stem cell medicine. The research and development activities are assigned to the Bio-technology business segment.

Quality Leadership

As the only private stem cell bank in Germany, Vita 34 can demonstrate medical applications from its own stored stem cell units. This is the result of observing the highest quality and safety standards in the cryo-preservation of umbilical cord blood and tissue. Thus, 46 percent of therapeutic stem cell applications reported to Cord Blood Europe, a European association of private umbilical cord blood banks, have been performed with preparations stored at Vita 34.

Leading Market Position

With some 150,000 stored stem cell units in the Group of which there are 5,000 donations, and existing space for up to 350,000 stem cell preparations, Vita 34 is the market leader in the German-speaking countries.

Strong Network with Relevant Multipliers

In order to allow the greatest number of parents to provide stem cells prophylactically for their children, Vita 34 serves a network of more than 15,000 OB/GYNs and has entered into some 2,000 agreements with birthing facilities.

International Presence – The Vita 34 Family

Vita 34 is represented in the European and global markets in a total of 29 countries via subsidiaries and cooperation partners. With its many years of experience and comprehensive expertise in the field of the private umbilical cord blood banking Vita 34 offers partners the highest quality in the storage of stem cells from umbilical cord blood and tissues “Made in Germany.”

Corporate Structure

The publicly traded Vita 34 AG company is the parent of the group. Vita 34 has the following subsidiaries and holds interests in businesses:

  • Vita 34 Gesellschaft für Zelltransplantate m.b.H. (Austria)
  • Novel Pharma S.L. (Spain)
    Secuvita S.L. (Spain)
  • VITA 34 Slovakia, s.r.o. (Slovakia)
  • Vita 34 ApS (Dänemark) – former Stemcare ApS
  • stellacure GmbH (Germany)
  • Bio Save d.o.o. (Serbia)
  • AS „Imunolita“ (Lithuania)

to top